Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Journal of Virology
|
June 29, 2004
Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection
Kyle Rosenke, Elizabeth A Fortunato
Plos Computational Biology
|
January 7, 2021
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
Guillaume Lingas, Kyle Rosenke, David Safronetz, et al.
Microorganisms
|
April 30, 2021
Lassa Virus Treatment Options
Frederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.
Journal of Virology
|
December 8, 2006
Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection
Min Hua Luo, Kyle Rosenke, Kamila Czornak, et al.
Journal of Virology
|
February 20, 2009
The presence of p53 influences the expression of multiple human cytomegalovirus genes at early times postinfection
Holger Hannemann, Kyle Rosenke, John M O'Dowd, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 2, 2019
Host Competency of the Multimammate Rat <i>Mastomys natalensis</i> Demonstrated by Prolonged Spirochetemias with the African Relapsing Fever Spirochete <i>Borrelia crocidurae</i>
Kristin Boardman, Kyle Rosenke, David Safronetz, et al.
Viruses
|
February 24, 2024
Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters
Joshua Marceau, David Safronetz, Cynthia Martellaro, et al.
Virology
|
September 23, 2016
Endogenous retroviruses mobilized during friend murine leukemia virus infection
Stefano Boi, Kyle Rosenke, Ethan Hansen, et al.
The Journal of Infectious Diseases
|
July 8, 2024
Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations
Shuntai Zhou, Nathan Long, Kyle Rosenke, et al.
Virology
|
February 4, 2006
An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection
Kyle Rosenke, Melanie A Samuel, Eric T McDowell, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Journal of Virology
|
June 29, 2004
Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection
Kyle Rosenke, Elizabeth A Fortunato
Plos Computational Biology
|
January 7, 2021
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
Guillaume Lingas, Kyle Rosenke, David Safronetz, et al.
Microorganisms
|
April 30, 2021
Lassa Virus Treatment Options
Frederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.
Journal of Virology
|
December 8, 2006
Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection
Min Hua Luo, Kyle Rosenke, Kamila Czornak, et al.
Journal of Virology
|
February 20, 2009
The presence of p53 influences the expression of multiple human cytomegalovirus genes at early times postinfection
Holger Hannemann, Kyle Rosenke, John M O'Dowd, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 2, 2019
Host Competency of the Multimammate Rat <i>Mastomys natalensis</i> Demonstrated by Prolonged Spirochetemias with the African Relapsing Fever Spirochete <i>Borrelia crocidurae</i>
Kristin Boardman, Kyle Rosenke, David Safronetz, et al.
Viruses
|
February 24, 2024
Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters
Joshua Marceau, David Safronetz, Cynthia Martellaro, et al.
Virology
|
September 23, 2016
Endogenous retroviruses mobilized during friend murine leukemia virus infection
Stefano Boi, Kyle Rosenke, Ethan Hansen, et al.
The Journal of Infectious Diseases
|
July 8, 2024
Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations
Shuntai Zhou, Nathan Long, Kyle Rosenke, et al.
Virology
|
February 4, 2006
An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection
Kyle Rosenke, Melanie A Samuel, Eric T McDowell, et al.
Page
of 9